GenMark Diagnostics Operating Income 2010-2018 | GNMK

GenMark Diagnostics operating income from 2010 to 2018. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
GenMark Diagnostics Annual Operating Income
(Millions of US $)
2017 $-60
2016 $-49
2015 $-42
2014 $-39
2013 $-35
2012 $-22
2011 $-24
2010 $-20
2009 $1
GenMark Diagnostics Quarterly Operating Income
(Millions of US $)
Q3 2018 $-11
Q2 2018 $-16
Q1 2018 $-11
Q4 2017 $-14
Q3 2017 $-15
Q2 2017 $-17
Q1 2017 $-14
Q4 2016 $-12
Q3 2016 $-12
Q2 2016 $-13
Q1 2016 $-13
Q4 2015 $-8
Q3 2015 $-11
Q2 2015 $-12
Q1 2015 $-10
Q4 2014 $-9
Q3 2014 $-10
Q2 2014 $-11
Q1 2014 $-9
Q4 2013 $-10
Q3 2013 $-12
Q2 2013 $-8
Q1 2013 $-4
Q4 2012 $-5
Q3 2012 $-6
Q2 2012 $-6
Q1 2012 $-5
Q4 2011 $-5
Q3 2011 $-6
Q2 2011 $-6
Q1 2011 $-7
Q4 2010 $-10
Q3 2010 $-5
Q2 2010 $-5
Q1 2010 $0
Q4 2009 $0
Q3 2009 $0
Q2 2009 $0
Q1 2009 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.280B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $97.045B 22.61
Intuitive Surgical (ISRG) United States $59.217B 58.26
Edwards Lifesciences (EW) United States $32.551B 34.83
Fresenius Medical Care AG KGaA (FMS) Germany $24.608B 16.66
IDEXX Laboratories (IDXX) United States $17.365B 49.60
ABIOMED (ABMD) United States $14.403B 103.49
DexCom (DXCM) United States $12.274B 0.00
Teleflex (TFX) United States $12.055B 27.37
Hologic (HOLX) United States $11.459B 18.80
Varian Medical Systems (VAR) United States $10.872B 26.93
STERIS (STE) United Kingdom $10.002B 26.54
LivaNova (LIVN) United Kingdom $6.106B 39.19
Masimo (MASI) United States $5.811B 37.68
Globus Medical (GMED) United States $5.097B 31.95
Penumbra (PEN) United States $4.712B 284.52
Integra LifeSciences Holdings (IART) United States $4.624B 22.52
Wright Medical Group (WMGI) Netherlands $3.695B 0.00
Cantel Medical (CMD) United States $3.586B 36.13
Inogen (INGN) United States $3.026B 65.32
Integer Holdings (ITGR) United States $2.776B 23.23
Halyard Health (AVNS) United States $2.304B 20.76
Glaukos (GKOS) United States $2.142B 0.00
OPKO Health (OPK) United States $1.993B 0.00
Tandem Diabetes Care (TNDM) United States $1.921B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
AxoGen (AXGN) United States $1.225B 0.00
Nevro (NVRO) United States $1.217B 0.00
Luminex (LMNX) United States $1.204B 43.56
Natus Medical (BABY) United States $1.146B 24.06
Pacific Biosciences Of California (PACB) United States $1.123B 0.00
Orthofix (OFIX) United States $1.108B 32.01
CryoLife (CRY) United States $1.094B 95.93
Tactile Systems Technology (TCMD) United States $1.081B 172.12
Intersect ENT (XENT) United States $0.952B 0.00
AngioDynamics (ANGO) United States $0.806B 28.19
Accelerate Diagnostics (AXDX) United States $0.782B 0.00
Mesa Laboratories (MLAB) United States $0.768B 45.43
ViewRay (VRAY) United States $0.663B 0.00
Veracyte (VCYT) United States $0.562B 0.00
Sientra (SIEN) United States $0.522B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.419B 0.00
Accuray (ARAY) United States $0.408B 0.00
SI-BONE INC (SIBN) United States $0.407B 0.00
Quotient (QTNT) Switzerland $0.374B 0.00
OrthoPediatrics (KIDS) United States $0.365B 0.00
Nuvectra (NVTR) United States $0.325B 0.00
Fluidigm (FLDM) United States $0.322B 0.00
Neuronetics (STIM) United States $0.318B 0.00
IRadimed (IRMD) United States $0.299B 78.06
SeaSpine Holdings (SPNE) United States $0.285B 0.00
RTI Surgical (RTIX) United States $0.278B 43.80
Pulse Biosciences (PLSE) United States $0.215B 0.00
T2 Biosystems (TTOO) United States $0.204B 0.00
Helius Medical Technologies (HSDT) United States $0.189B 0.00
Ekso Bionics Holdings (EKSO) United States $0.127B 0.00
Alphatec Holdings (ATEC) United States $0.123B 0.00
Ra Medical Systems (RMED) United States $0.103B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.094B 0.00
Second Sight Medical Products (EYES) United States $0.090B 0.00
Apollo Endosurgery (APEN) United States $0.077B 0.00
EDAP TMS (EDAP) France $0.076B 0.00
Restoration Robotics (HAIR) United States $0.072B 0.00
Viveve Medical (VIVE) United States $0.068B 0.00
Biosig Technologies (BSGM) United States $0.066B 0.00
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Vermillion (VRML) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
Lianluo Smart (LLIT) China $0.028B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Titan Medical (TMDI) Canada $0.027B 0.00
ENDRA Life Sciences (NDRA) United States $0.022B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Microbot Medical (MBOT) United States $0.010B 0.00
ReWalk Robotics (RWLK) Israel $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.003B 0.00
Amedica (SINT) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00